The corporate bodies in Addtech AB are comprised of the general meeting of shareholders, the Board of Directors, the President and the auditors. Addtech AB operates under Swedish limited liability corporate law and the rules that follow from the fact that the Addtech share is listed on Stockholmsbörsen (the Stockholm Stock Exchange).

Hållbarhetsredovisning ADDTECHS HÅLLBARHETSREDOVISNING. Sedan 2011 publicerar Addtech en hållbarhetsredovisning. Detta är en viktig del i hållbarhetsarbetet då den ger medarbetare, ägare och andra intressenter möjlighet att ta del av hur CSR-arbetet utvecklas.

Board member: among others, Bergvik Skog The Board of Directors holds overall responsibility for Addtech’s organisation and management of Addtech’s business. It is responsible for the Group's long-term development and strategy, for continuously monitoring and assessing the Group's operations, and for any other task conferred by the Swedish Companies Act. The Annual General Meeting in August 2019 authorised the Board of Directors to repurchase a maximum of 10 percent of all shares in the Company during the period extending until the 2020 Annual General Meeting. During the financial year Addtech repurchased 150,000 of its own Class B shares. From February 2018 until July 2020, Dr.h.c.

Chairman of the Board: Avillion LLP, Hansa Medical AB, Trialbee AB and Sigrid Therapeutics. Board member: UCB Pharma and Agenus Inc. Addtech är en svensk, börsnoterad teknikhandelskoncern med en lång historik av uthållig, lönsam tillväxt. Vi förvärvar, äger och utvecklar självständiga dotterbolag som skapar tekniska, ekonomiska och hållbara mervärden för såväl kunder som leverantörer. The Board of Directors holds overall responsibility for Addtech’s organisation and management of Addtech’s business. It is responsible for the Group's long-term development and strategy, for continuously monitoring and assessing the Group's operations, and for any other task conferred by the Swedish Companies Act. Addtech består af ca. 130 selvstændige datterselskaber. Det betyder, at beslutninger om virksomhedernes aktiviteter tages i nærheden af markedet.

The Nomination Committee´s proposal for new Chairman of the Board of Addtech AB Tue, Mar 09, 2021 15:45 CET. The Nomination Committee proposes that Board member Kenth Eriksson will be elected as Chairman of the Board at the 2021 Annual General Meeting.

Addtech Value-adding tech provider; Verksamhet; Affärsområden. 5.

Rutger Arnhult is CEO and board member of Klövern AB (publ) and Corem Property Bergman & Beving AB and OptiGroup AB, board member of Addtech AB,

Under denna avdelning, Bolagsstyrning, presenteras hur Addtech arbetar med bolagsstyrningsfrågor. Hållbarhetsredovisning ADDTECHS HÅLLBARHETSREDOVISNING.

Professional experience: CEO of Addtech AB and senior positions within Bergman & Beving and previously within Alfred Berg/ ABN Amro. board assignments: Chairman of the Board at Bergman & Beving, AddLife and OptiGroup. Board member at Bufab, Camfil and M2 Asset Management. Professional experience: CEO of Addtech AB and senior positions within Bergman & Beving and previously within Alfred Berg/ABN Amro. Shareholding: 10,080 . Class A shares, 92,804 Class B shares. Born 1973.
Helsingborg lärarutbildning

Shareholding: 4,482 Class B shares. Call options equivalent to 19,500 shares (including related parties).

Employed by the Group since 2004. Professional experience: Business Controller Addtech Power Solutions, several accountancy roles at Addtech, auditor at Mazars (SET) Revisionsbyrå.Shareholding: 4,482 Class B shares.
Overklaga sjukpenning

musikhögskola ingesund
mammografi hudiksvall boka tid
maria hagberg hedersvåld
lena strom kulturkrabaten
norwegians in wisconsin
helen mirren
apple vision sandy

Stockopedia rates Addtech AB as a Adventurous High Flyer . BRIEF-Addtech Proposes Board Member Kenth Eriksson To Be Elected As Chairman Of Board.

Born: 1958 Formerly CEO of H. Lundbeck A/S, as well as director of Wyeth Pharmaceuticals, EMEA/Canada & BioPharma, and a number of other senior positions in Wyeth. Chairman of the Board: Avillion LLP, Hansa Medical AB, Trialbee AB and Sigrid Therapeutics. Board member: UCB Pharma and Agenus Inc. Proposal by the Board of Directors of Addtech AB (publ) for resolution at the Annual General Meeting to be held 29 August 2012.

Konkurs pitea
förtydligad läroplan för förskolan

The Nomination Committee's proposal for new Chairman of the Board of Addtech AB. Publicerad: 2021-03-09 (Cision) Valberedningens förslag till ny ordförande i Addtech AB. Publicerad: 2021-03-09 (Cision)

Addtech AB operates under Swedish limited liability corporate law and the rules that follow from the fact that the Addtech share is listed on Stockholmsbörsen (the Stockholm Stock Exchange). Other Board assignments: Chairman of the Boards of AddLife, Momentum Group, OptiGroup and Prosero Security Group. Board member at Camfil and M2 Asset Management. Professional experience: CEO of Addtech AB and senior positions within Bergman & Beving and previously within Alfred Berg/ ABN Amro. Shareholders who wish to refer a case to the annual general meeting should send this in writing to the Board at the latest seven weeks before the date of the annual general meeting.